Cargando…
Strategies towards in vivo imaging of active transglutaminase type 2 using positron emission tomography
Transglutaminase type 2 (TG2) is increasingly linked to the pathogenesis of several diseases, such as celiac disease, cancer, and fibrotic and neurodegenerative diseases. In parallel with becoming an attractive target for therapy, interest in the development of compounds for in vivo imaging of TG2 i...
Autores principales: | van der Wildt, Berend, Lammertsma, Adriaan A., Drukarch, Benjamin, Windhorst, Albert D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5332496/ https://www.ncbi.nlm.nih.gov/pubmed/27380031 http://dx.doi.org/10.1007/s00726-016-2288-y |
Ejemplares similares
-
In vivo evaluation of two tissue transglutaminase PET tracers in an orthotopic tumour xenograft model
por: van der Wildt, Berend, et al.
Publicado: (2018) -
In-vivo monitoring of anti-folate therapy in arthritic rats using [(18)F]fluoro-PEG-folate and positron emission tomography
por: Chandrupatla, Durga M. S. H., et al.
Publicado: (2017) -
Positron Emission Tomography as a Method for Measuring Drug Delivery to Tumors in vivo: The Example of [(11)C]docetaxel
por: van der Veldt, Astrid A. M., et al.
Publicado: (2013) -
Promising potential of new generation translocator protein tracers providing enhanced contrast of arthritis imaging by positron emission tomography in a rat model of arthritis
por: Gent, Yoony YJ, et al.
Publicado: (2014) -
Imaging Biotin
Trafficking In Vivo with Positron Emission
Tomography
por: Bongarzone, Salvatore, et al.
Publicado: (2020)